Quick Answer
Sarepta Therapeutics, Inc. reported Total Revenue of $2.20 billion for fiscal year 2025.
Sarepta Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.20B | +15.6% |
| 2024 | $1.90B | +53.0% |
| 2023 | $1.24B | +33.3% |
| 2022 | $933.01M | +32.9% |
| 2021 | $701.89M | +30.0% |
| 2020 | $540.10M | +41.8% |
| 2019 | $380.83M | +26.5% |
| 2018 | $301.03M | +94.7% |
| 2017 | $154.58M | +2751.6% |
| 2016 | $5.42M | +332.6% |
| 2015 | $1.25M | -87.2% |
| 2014 | $9.76M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $399.36M | -14.5% | -34.6% |
| June 30, 2025 | $611.09M | +68.4% | -18.0% |
| March 31, 2025 | $744.86M | +80.2% | +59.4% |
| September 30, 2024 | $467.17M | +40.8% | +28.7% |
| June 30, 2024 | $362.93M | +38.9% | -12.2% |
| March 31, 2024 | $413.46M | +63.1% | +24.6% |
| September 30, 2023 | $331.82M | +44.1% | +27.0% |
| June 30, 2023 | $261.24M | +11.9% | +3.1% |
- Sarepta Therapeutics, Inc. showed an increase of +15.6% in Total Revenue compared to the prior fiscal year.
- Over the 2014–2025 period, Sarepta Therapeutics, Inc.’s total revenue has grown by 22429.8% (from $9.76 million to $2.20 billion).
- The most recent figure is from Sarepta Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: